Objective: We aimed to investigate the prevalence of idiopathic intracranial hypertension (IIH) in patients with migraine by screening for papilledema.
Materials And Methods: We have included all the patients with migraine who applied to our neurology clinic during December 2019 and accepted to participate in the study. The demographic and clinical characteristics including migraine subtype (episodic/chronic), headache frequency per month, and headache characteristics of all patients were interrogated. Besides, the presence of fibromyalgia (FM) and chronic fatigue syndrome (CFS) was noted. Fundus examination was performed in all of the patients and the presence of papilledema was noted.
Results: Overall, 158 consecutive migraineurs were included in this study. The mean age of the group was 35.9 ± 9.9 and the female/male ratio was 134/24. Papilledema was determined in 10 (6%) patients. There was a past medical history of having IIH in one of these patients. In four of the patients, the diagnosis of IIH was newly established. Comparative analyses between episodic migraineurs and chronic migraineurs revealed that female gender was more prevalent in chronic migraineurs (p = 0.00) and the comorbidities of FM and CFS were more common in chronic migraineurs. Remarkably, papilledema was found to be more common in chronic migraineurs. The results of the logistic regression analyses revealed that obesity was the only predictor for the presence of papilledema (p = 0.014).
Conclusion: Our results may suggest that IIH should be kept in mind as a notable comorbidity in migraineurs, particularly in the subgroup of obese patients with chronic migraine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10072-020-04473-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Healthy core: Harmonizing brain MRI for supporting multicenter migraine classification studies.
PLoS One
December 2024
ASU-Mayo Center for Innovative Imaging, Tempe, Arizona, United States of America.
Multicenter and multi-scanner imaging studies may be necessary to ensure sufficiently large sample sizes for developing accurate predictive models. However, multicenter studies, incorporating varying research participant characteristics, MRI scanners, and imaging acquisition protocols, may introduce confounding factors, potentially hindering the creation of generalizable machine learning models. Models developed using one dataset may not readily apply to another, emphasizing the importance of classification model generalizability in multi-scanner and multicenter studies for producing reproducible results.
View Article and Find Full Text PDFA study of changes in hematologic parameters in patients with migraine.
Clin Exp Immunol
December 2024
Department of Neurology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230001, China.
Introduction: To evaluate the characteristics of hematological parameters and peripheral inflammatory markers in migraine, including chronic migraine (CM) and episodic migraine (EM), and to explore their underlying mechanisms.
Method: A total of 88 subjects were enrolled, 58 with migraine (28 with chronic migraine and 30 with episodic migraine) and 30 healthy controls. All subjects were matched for age, gender and body mass index (BMI), and peripheral blood was collected.
[Joint guideline of the Headache Working Group of the Hungarian Headache Society (MFT) and the Hungarian Pain Society (MOFT) for the practical care of acute and chronic migraine].
Ideggyogy Sz
November 2024
Fejér Megyei Szent György Egyetemi Oktató Kórház, Neurológiai Osztály, Székesfehérvár.
Migraine is a disabling primary headache disorder that directly affects a significant proportion of the population. Despite its widespread prevalence, migraine remains under-diagnosed and under-treated. To support clinical decision-making, we convened a panel of experts to develop a clinical approach to the diagnosis and management of migraine.
View Article and Find Full Text PDFDirect Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients.
J Clin Med Res
December 2024
College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Article Synopsis
- The study aimed to compare the effectiveness and safety of two preventive treatments for chronic migraines: anti-calcitonin gene-related peptide (anti-CGRP) and botulinum neurotoxin (BoNT), involving 80 patients at King Fahad University Hospital.
- Both treatments resulted in significant decreases in migraine pain scores and disability after 9 months, with anti-CGRP showing slightly better results, though not statistically significant.
- Adverse effects were common in both groups, with "headache" being the most frequent; notably, more patients in the anti-CGRP group reported joint stiffness compared to those receiving BoNT.
Ketogenic Diet Improves Sleep Quality and Daytime Sleepiness in Chronic Migraine: A Pilot Study.
Neurol Int
October 2024
Clinical Neurology Unit, Department of Head, Neck and Neurosurgery, Udine University Hospital, Piazzale Santa Maria della Misericordia 15, 33100 Udine, Italy.
Aims: The aim of this study is to assess the sleep quality and daytime sleepiness improvement in chronic migraineurs after 6 months of a 2:1 KD (ketogenic diet) and LGID (low-glycemic-index diet).
Methods: Twenty-six patients underwent 2:1 KD (11 patients) and LGID (15 patients). PSQI (Pittsburgh sleep quality index) and ESS (Epworth sleepiness scale) were administered at the baseline and the 3-month and 6-month follow-up.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!